You are here

Genetic predictors of fibrin D-dimer levels in healthy adults.

TitleGenetic predictors of fibrin D-dimer levels in healthy adults.
Publication TypeJournal Article
Year of Publication2011
AuthorsSmith, NL, Huffman, JE, Strachan, DP, Huang, J, Dehghan, A, Trompet, S, Lopez, LM, Shin, S-Y, Baumert, J, Vitart, V, Bis, JC, Wild, SH, Rumley, A, Yang, Q, Uitterlinden, AG, Stott, DJ, Davies, G, Carter, AM, Thorand, B, Polasek, O, McKnight, B, Campbell, H, Rudnicka, AR, Chen, M-H, Buckley, BM, Harris, SE, Peters, A, Pulanic, D, Lumley, T, de Craen, AJM, Liewald, DC, Gieger, C, Campbell, S, Ford, I, Gow, AJ, Luciano, M, Porteous, DJ, Guo, X, Sattar, N, Tenesa, A, Cushman, M, P Slagboom, E, Visscher, PM, Spector, TD, Illig, T, Rudan, I, Bovill, EG, Wright, AF, McArdle, WL, Tofler, G, Hofman, A, Westendorp, RGJ, Starr, JM, Grant, PJ, Karakas, M, Hastie, ND, Psaty, BM, Wilson, JF, Lowe, GDO, O'Donnell, CJ, Witteman, JCM, J Jukema, W, Deary, IJ, Soranzo, N, Koenig, W, Hayward, C
JournalCirculation
Volume123
Issue17
Pagination1864-72
Date Published2011 May 03
ISSN1524-4539
KeywordsAdult, Aged, Blood Coagulation, European Continental Ancestry Group, Factor V, Female, Fibrin Fibrinogen Degradation Products, Fibrinogen, Genetic Testing, Genome-Wide Association Study, Humans, Male, Middle Aged, Reference Values, Thromboplastin
Abstract<p><b>BACKGROUND: </b>Fibrin fragment D-dimer, one of several peptides produced when crosslinked fibrin is degraded by plasmin, is the most widely used clinical marker of activated blood coagulation. To identity genetic loci influencing D-dimer levels, we performed the first large-scale, genome-wide association search.</p><p><b>METHODS AND RESULTS: </b>A genome-wide investigation of the genomic correlates of plasma D-dimer levels was conducted among 21 052 European-ancestry adults. Plasma levels of D-dimer were measured independently in each of 13 cohorts. Each study analyzed the association between ≈2.6 million genotyped and imputed variants across the 22 autosomal chromosomes and natural-log–transformed D-dimer levels using linear regression in additive genetic models adjusted for age and sex. Among all variants, 74 exceeded the genome-wide significance threshold and marked 3 regions. At 1p22, rs12029080 (P=6.4×10(-52)) was 46.0 kb upstream from F3, coagulation factor III (tissue factor). At 1q24, rs6687813 (P=2.4×10(-14)) was 79.7 kb downstream of F5, coagulation factor V. At 4q32, rs13109457 (P=2.9×10(-18)) was located between 2 fibrinogen genes: 10.4 kb downstream from FGG and 3.0 kb upstream from FGA. Variants were associated with a 0.099-, 0.096-, and 0.061-unit difference, respectively, in natural-log–transformed D-dimer and together accounted for 1.8% of the total variance. When adjusted for nonsynonymous substitutions in F5 and FGA loci known to be associated with D-dimer levels, there was no evidence of an additional association at either locus.</p><p><b>CONCLUSIONS: </b>Three genes were associated with fibrin D-dimer levels. Of these 3, the F3 association was the strongest, and has not been previously reported.</p>
DOI10.1161/CIRCULATIONAHA.110.009480
Alternate JournalCirculation
PubMed ID21502573
PubMed Central IDPMC3095913
Grant ListM01-RR00425 / RR / NCRR NIH HHS / United States
N02-HL-6-4278 / HL / NHLBI NIH HHS / United States
N01-HC-25195 / HC / NHLBI NIH HHS / United States
HL073410 / HL / NHLBI NIH HHS / United States
CZB/4/710 / / Chief Scientist Office / United Kingdom
R01 HL095080 / HL / NHLBI NIH HHS / United States
U01 HL080295 / HL / NHLBI NIH HHS / United States
U.1275.00.001(61128) / / Medical Research Council / United Kingdom
MC_U127561128 / / Medical Research Council / United Kingdom
N01 HC015103 / HC / NHLBI NIH HHS / United States
079895 / / Wellcome Trust / United Kingdom
CZB/4/276 / / Chief Scientist Office / United Kingdom
091746/Z/ / / Wellcome Trust / United Kingdom
R01 HL087652 / HL / NHLBI NIH HHS / United States
N01HC55222 / HL / NHLBI NIH HHS / United States
N01-HC-85086 / HC / NHLBI NIH HHS / United States
N01HC85086 / HL / NHLBI NIH HHS / United States
SAG09977 / / Biotechnology and Biological Sciences Research Council / United Kingdom
U01 DK062418 / DK / NIDDK NIH HHS / United States
P30 DK063491 / DK / NIDDK NIH HHS / United States
R01 HL 087652 / HL / NHLBI NIH HHS / United States
N01-HC-55222 / HC / NHLBI NIH HHS / United States
068545 / / Wellcome Trust / United Kingdom
K24 DK080140 / DK / NIDDK NIH HHS / United States
N01-HC-75150 / HC / NHLBI NIH HHS / United States
079996 / / Wellcome Trust / United Kingdom
MC_PC_U127561128 / / Medical Research Council / United Kingdom
091746 / / Wellcome Trust / United Kingdom
M01 RR000425 / RR / NCRR NIH HHS / United States
HL095080 / HL / NHLBI NIH HHS / United States
N01HC75150 / HL / NHLBI NIH HHS / United States
N01HC25195 / HL / NHLBI NIH HHS / United States
DK063491 / DK / NIDDK NIH HHS / United States
G0700704 / / Medical Research Council / United Kingdom
N01-HC-85079 / HC / NHLBI NIH HHS / United States
068545/Z/02 / / Wellcome Trust / United Kingdom
BB/F019394/1 / / Biotechnology and Biological Sciences Research Council / United Kingdom
MC_QA137934 / / Medical Research Council / United Kingdom
N01HC85079 / HL / NHLBI NIH HHS / United States
R01 HL073410 / HL / NHLBI NIH HHS / United States
076113/B/04/Z / / Wellcome Trust / United Kingdom
N01 HC045133 / HC / NHLBI NIH HHS / United States
G0000934 / / Medical Research Council / United Kingdom
N01 HC035129 / HC / NHLBI NIH HHS / United States